Trace impurities identified by high performance liquid chromatography/electrospray mass spectrometry in two different synthetic batches of 4-boronophenylalanine

Abstract

The chemical purity of two synthetic 4-boronophenylalanine (BPA, C 9 H 12 O 4 BN) batches produced by two different pathways were investigated by high performance liquid chromatography/electrospray mass spectrometry. Currently, BPA is one of the most important clinical boron carriers in boron neutron capture therapy (BNCT). Low energy tandem mass spectrometry was used to elucidate the structure of BPA and two minor signals eluting later than the major compound. In the mass spectrom a very intense singly charged [MH] ion m/z 209 was observed. The ratio of 10 B/ 11 B was estimated also. The product-ion spectrum of BPA shows distinct losses of 18, 46 and 89 u. Based on the fragmentation of the major compound two impurities were characterized. In both cases an intense molecular ion, 244 u and 285 u was observed. Knowing the synthetic pathway and fragmentation of the major compound we suggest the following formulae for the impurities: C 9 H 10 O 2 BrN and C 15 H 16 O 4 BN. Further evidence to the first impurity is the detected isotope pattern, corresponding to bromine. The existence of the impurities can be explained and avoided by exploring the synthetic pathways used. High performance liquid chromatography/electrospray mass spectrometry was demonstrated to be an important novel analytical instrument to check the purity of BPA prior to clinical studies in BNCT. #

Characterization of a Novel Trace-Level Impurity in Lisinopril Using Multi-Stage Mass Spectrometry

“…Liquid chromatography in combination with multi-stage mass spectrometry (HPLC/MS n ), useful for its capability to afford both molecular mass and some structural information, is particularly useful for rapid and accurate characterization of structurally related compounds, without the need for time-consuming and tedious preparative separation and purification. [5][6][7] In this paper, we describe the characterization of a novel impurity detected in the bulk drug lisinopril using HPLC/MS n .…”

Determination of Boron-Containing Compounds in Urine and Blood Plasma from Boron Neutron Capture Therapy Patients. The Importance of Using Coupled Techniques

“…Separation of intact BPA from endogenous substances in biological tissues and blood , and from trace impurities in synthetic mixtures using C8 and C18 materials with UV 9,10,12 and ESI-MS detection 11 has been reported. In the present study, porous graphitic carbon (PGC) was chosen as separation media, because this material can selectively retain not only hydrofobic analytes but also polar compounds in, for example, biomedical and pharmaceutical analyses. − Another advantage with the PGC material is that it can be used over the entire pH range, so that acidic samples and mobile phases can be used without any special precautions.…”